These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27373839)

  • 1. Trimerization Dictates Solution Opalescence of a Monoclonal Antibody.
    Yang TC; Langford AJ; Kumar S; Ruesch JC; Wang W
    J Pharm Sci; 2016 Aug; 105(8):2328-37. PubMed ID: 27373839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opalescence in monoclonal antibody solutions and its correlation with intermolecular interactions in dilute and concentrated solutions.
    Raut AS; Kalonia DS
    J Pharm Sci; 2015 Apr; 104(4):1263-74. PubMed ID: 25556561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opalescence of an IgG2 monoclonal antibody solution as it relates to liquid-liquid phase separation.
    Mason BD; Zhang L; Remmele RL; Zhang J
    J Pharm Sci; 2011 Nov; 100(11):4587-96. PubMed ID: 21638285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in Protein Solutions.
    Raut AS; Kalonia DS
    Mol Pharm; 2016 May; 13(5):1431-44. PubMed ID: 27017836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cosolute effects on the chemical potential and interactions of an IgG1 monoclonal antibody at high concentrations.
    Scherer TM
    J Phys Chem B; 2013 Feb; 117(8):2254-66. PubMed ID: 23330570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Opalescence in low Volume Monoclonal Antibody Solutions Enabled by Microscale Nephelometry.
    Kingsbury JS; Lantz MM; Saini A; Wang MZ; Gokarn YR
    J Pharm Sci; 2021 Sep; 110(9):3176-3182. PubMed ID: 34004217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine suppresses opalescence and liquid-liquid phase separation in IgG solutions.
    Oki S; Nishinami S; Shiraki K
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1708-1712. PubMed ID: 29981328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of colloidal stability of high concentration protein formulations.
    Garidel P; Blume A; Wagner M
    Pharm Dev Technol; 2015 May; 20(3):367-74. PubMed ID: 24392929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1.
    Hu Y; Arora J; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):340-352. PubMed ID: 31201906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of salt-induced reversible self-association on the elution behavior of a monoclonal antibody in cation exchange chromatography.
    Luo H; Macapagal N; Newell K; Man A; Parupudi A; Li Y; Li Y
    J Chromatogr A; 2014 Oct; 1362():186-93. PubMed ID: 25182858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing Reversible Protein Association at Moderately High Concentration Via Composition-Gradient Static Light Scattering.
    Some D; Pollastrini J; Cao S
    J Pharm Sci; 2016 Aug; 105(8):2310-8. PubMed ID: 27364461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of Interaction Parameters for Reversibly Self-Associating Antibodies: A Comparative Analysis.
    Hopkins MM; Lambert CL; Bee JS; Parupudi A; Bain DL
    J Pharm Sci; 2018 Jul; 107(7):1820-1830. PubMed ID: 29571738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association.
    Sukumar M; Doyle BL; Combs JL; Pekar AH
    Pharm Res; 2004 Jul; 21(7):1087-93. PubMed ID: 15290846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energetic Dissection of Mab-Specific Reversible Self-Association Reveals Unique Thermodynamic Signatures.
    Hopkins MM; Parupudi A; Bee JS; Bain DL
    Pharm Res; 2021 Feb; 38(2):243-255. PubMed ID: 33604786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies.
    Esfandiary R; Hayes DB; Parupudi A; Casas-Finet J; Bai S; Samra HS; Shah AU; Sathish HA
    J Pharm Sci; 2013 Sep; 102(9):3089-99. PubMed ID: 23794522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.
    Liu J; Nguyen MD; Andya JD; Shire SJ
    J Pharm Sci; 2005 Sep; 94(9):1928-40. PubMed ID: 16052543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viscosity behavior of high-concentration monoclonal antibody solutions: correlation with interaction parameter and electroviscous effects.
    Yadav S; Shire SJ; Kalonia DS
    J Pharm Sci; 2012 Mar; 101(3):998-1011. PubMed ID: 22113861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermolecular interactions of IgG1 monoclonal antibodies at high concentrations characterized by light scattering.
    Scherer TM; Liu J; Shire SJ; Minton AP
    J Phys Chem B; 2010 Oct; 114(40):12948-57. PubMed ID: 20849134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.
    Yadav S; Shire SJ; Kalonia DS
    J Pharm Sci; 2010 Dec; 99(12):4812-29. PubMed ID: 20821382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation.
    Salinas BA; Sathish HA; Bishop SM; Harn N; Carpenter JF; Randolph TW
    J Pharm Sci; 2010 Jan; 99(1):82-93. PubMed ID: 19475558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.